Probi AAQS 2025
Probi AAQS
3
Ticker
PROB.ST
ISIN
SE0001280355
WKN
A0JKFA
Probi has a current AAQS of 3.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Probi in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
Probi Aktienanalyse
What does Probi do?
Probi AB is a Swedish company that specializes in the development and production of probiotic products. Founded in 1991 as a spin-off from Lund Institute of Technology, Probi is now represented in Sweden, the USA, and India with approximately 200 employees. The business model of Probi is based on research and development of probiotic bacterial cultures, as well as marketing probiotic products developed in collaboration with customers and partners. The company's business divisions are divided into probiotic products and research and development. Probiotic products: Probi produces a wide range of probiotic products, including dietary supplements, functional foods, animal feed, and medical devices. These products contain live microorganisms intended to support gut health and strengthen the immune system. Probi works closely with customers and partners to develop tailored solutions. Research and development: An important part of Probi's business is the research and development of probiotic bacterial cultures. Research findings serve as the basis for new products and applications. Probi has its own research department equipped with state-of-the-art laboratory technologies. In addition, Probi collaborates closely with partners from the academic and industrial sectors to explore new technologies and applications. Probi's history originally began in the 1980s at Lund Institute of Technology in Sweden, where the foundation for the development of probiotics was laid. In 1991, Probi was established as a spin-off from the institute, initially focusing on research and development of probiotic bacterial cultures. Over the following years, the company expanded internationally and developed more and more products and applications. Today, Probi is a leading global provider of probiotic products and solutions. Probi's products include probiotic capsules and tablets, probiotic yogurts, beverages, and dietary supplements. These products are intended to stabilize gut flora and strengthen the immune system. Additionally, Probi offers animal feed with probiotic bacterial cultures to promote the health of livestock. An important aspect of Probi is its collaboration with partners and customers. Through these partnerships, innovative products and solutions are developed to meet the needs of customers. Probi works closely with the food industry, healthcare sector, and animal feed industry. The future of Probi looks promising. The company aims to continue developing innovative products and solutions to promote the health of humans and animals. A strong growth strategy will also be pursued to further expand international presence. Probi ist eines der beliebtesten Unternehmen auf Eulerpool.com.Frequently Asked Questions about Probi stock
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Probi
Our stock analysis for Probi Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Probi Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
